U.S. market Closed. Opens in 11 hours 30 minutes

AEMD | Aethlon Medical, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-312000-03-311999-03-311998-03-311997-03-31
RevenueN/A574.25K294.17K659.10K650.19K229.62K149.62K392.07K886.57K762.42K1.62M1.23M1.36MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue359.06K265.30K154.22KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A316.12KN/AN/A
Gross Profit-359.06K308.94K139.95K659.10K650.19K229.62KN/AN/AN/AN/AN/AN/A1.36MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-316.12KN/AN/A
Operating Expenses12.28M12.62M10.72M8.55M6.98M6.23M4.98M6.49M5.27M4.76M4.68M4.81M4.47M4.56M2.85M2.92M2.89M2.08M2.09M2.18M995.55K1.64M2.27M2.09M889.69K24.46K3.60K1.53K
Selling, General & Admin9.76M12.47M10.72M8.55M6.58M6.23M4.98M6.49M5.27M4.76M4.68M4.81M4.47M4.56M2.85M2.92M2.89M2.08M2.01M2.18M995.55K1.64M2.07M1.87M857.73KN/AN/AN/A
Research & Development2.52M2.75M2.34M2.07M927.00K896.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A81.72KN/AN/AN/A204.20K228.42K31.96K24.46K3.60K1.53K
Operating Income-12.64M-11.90M-10.42M-7.89M-5.93M-6.00M-4.83M-6.10M-4.38M-3.99M-3.06M-3.58M-3.11M-4.56M-2.85M-2.92M-2.89M-2.08M-2.09M-2.18M-995.55K-1.64M-2.27M-2.09M-889.69K-340.58K-3.60K-1.53K
Other Expenses / Income428.40K-131.15K-5.00-1.58K-450.05K-220.49K-868.72K-1.21M-573.78K-2.99M-10.38M-1.32M-4.14M2.77M-163.26K-1.39M71.81K-3.55M-456.67KN/AN/A-334.30K-1.72M-2.33M-404.53K-11.48KN/AN/A
Before Tax Income-12.21M-12.03M-10.42M-7.89M-6.38M-6.22M-5.70M-7.31M-4.96M-6.98M-13.44M-4.89MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-4.00M-4.42M-1.29M-352.05KN/AN/A
Income Tax Expenses3.00N/A-4.80K-6.37K-6.09K-24.79KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A5.16K625.00N/AN/A
Net Income-12.21M-12.03M-10.42M-7.89M-6.37M-6.19M-5.68M-7.28M-4.87M-6.80M-13.36M-4.89M-8.11M-5.71M-4.57M-6.08M-4.14M-6.02M-2.92M-2.10M-1.52M-2.46M-4.00M-4.42M-1.30M-352.68K-3.60K-1.53K
Interest ExpensesN/AN/AN/A1.58K54.23K220.49K361.60K304.33K573.78K452.28K1.29M1.01M859.14K3.95M1.56M1.77MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding2.51M2.05M1.48M1.21M341.48K120.83K821.14K517.62K492.92K372.96K258.75K198.97K135.69K92.81K75.49K57.26K45.86K35.92K26.07K18.72K10.91K7.40K5.12K3.71K3.48K2.01K682.001.70K
Diluted Shares Outstanding2.51M2.05M1.48M1.21M341.48K120.83K821.14K517.62K492.92K372.96K258.75K198.97K135.69K92.81K75.49K57.26K45.86K35.92K26.07K18.72K10.91K7.40K5.12K3.71K3.48K2.01K682.001.70K
EBITDA-12.28M-11.66M-10.30M-7.85M-5.90M-5.97M-5.28M-6.94M-4.26M-6.31M-12.05M-3.88M-7.23M-4.54M-2.84M-1.39M-1.68M-1.84M-1.77M-2.07M-868.55K-1.48M-2.07M-1.87M-857.73K-316.12K-3.60K-1.53K
EBITDA Margin0.00%-2,030.10%-3,500.48%-1,191.25%-907.99%-2,599.16%-3,530.36%-1,769.92%-480.51%-827.31%-742.03%-315.16%-532.13%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-12.21M-12.03M-10.42M-7.89M-6.33M-6.00M-5.32M-6.97M-4.30M-6.34M-12.07M-3.89M-7.25M-1.76M-3.01M-4.31M-4.14M-6.02M-2.92M-2.10M-1.52M-2.46M-4.00M-4.42M-1.29M-352.05K-3.60K-1.53K
EBIT Margin0.00%-2,094.89%-3,542.53%-1,197.31%-972.92%-2,612.53%-3,554.19%-1,778.18%-484.85%-832.21%-743.33%-316.01%-533.40%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-312000-03-311999-03-311998-03-311997-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙